IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

被引:1004
作者
Maeda, S
Kamata, H
Luo, JL
Leffert, H
Karin, M
机构
[1] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.cell.2005.04.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
I kappa B kinase beta (IKK beta), required for NF-kappa B activation, links chronic inflammation with carcinogenesis. We investigated whether IKK beta is involved in chemically induced liver cancer, a model not involving overt inflammation. Surprisingly, mice lacking IKK beta only in hepatocytes (Ikk beta(Delta hep) mice) exhibited a marked increase in hepatocarcinogenesis caused by diethylnitrosamine (DEN). This correlated with enhanced reactive oxygen species (ROS) production, increased JNK activation, and hepatocyte death, giving rise to augmented compensatory proliferation of surviving hepatocytes. Brief oral administration of an antioxidant around the time of DEN exposure blocked prolonged JNK activation and compensatory proliferation and prevented excessive DEN-induced carcinogenesis in Ikk beta(Delta hep) mice. Decreased hepatocarcinogenesis was also found in mice lacking IKKP in both hepatocytes and hematopoietic-derived Kupffer cells. These mice exhibited reduced hepatocyte regeneration and diminished induction of hepatomitogens, which were unaltered in Ikk beta(Delta hep) mice. IKK beta, therefore, orchestrates inflammatory crosstalk between hepatocytes and hematopoietic-derived cells that promotes chemical hepatocarcinogenesis.
引用
收藏
页码:977 / 990
页数:14
相关论文
共 55 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   CARCINOGENESIS AND TUMOR PATHOGENESIS [J].
BERENBLUM, I .
ADVANCES IN CANCER RESEARCH, 1954, 2 :129-175
[3]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[4]   Regulation of a-fetoprotein by nuclear factor-κB protects hepatocytes from tumor necrosis factor-α cytotoxicity during fetal liver development and hepatic oncogenesis [J].
Cavin, LG ;
Venkatraman, M ;
Factor, VM ;
Kaur, S ;
Schroeder, I ;
Mercurio, F ;
Beg, AA ;
Thorgeirsson, SS ;
Arsura, M .
CANCER RESEARCH, 2004, 64 (19) :7030-7038
[5]  
CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2
[6]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[7]   NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia [J].
Dajee, M ;
Lazarov, M ;
Zhang, JY ;
Cai, T ;
Green, CL ;
Russell, AJ ;
Marinkovich, MP ;
Tao, SY ;
Lin, Q ;
Kubo, Y ;
Khavari, PA .
NATURE, 2003, 421 (6923) :639-643
[8]   CORRELATION OF O-4-ETHYLDEOXYTHYMIDINE ACCUMULATION, HEPATIC INITIATION AND HEPATOCELLULAR-CARCINOMA INDUCTION IN RATS CONTINUOUSLY ADMINISTERED DIETHYLNITROSAMINE [J].
DYROFF, MC ;
RICHARDSON, FC ;
POPP, JA ;
BEDELL, MA ;
SWENBERG, JA .
CARCINOGENESIS, 1986, 7 (02) :241-246
[9]   Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 [J].
Eferl, R ;
Ricci, R ;
Kenner, L ;
Zenz, R ;
David, JP ;
Rath, M ;
Wagner, EF .
CELL, 2003, 112 (02) :181-192
[10]  
ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407